[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

MRD Testing-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data

December 2021 | 145 pages | ID: M8FEC069DCABEN
MIReports Co., Limited

US$ 3,680.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

MRD Testing-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on MRD Testing industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Top 20 Countries Market Size of MRD Testing 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of MRD Testing worldwide and market share by regions, with company and product introduction, position in the MRD Testing market
Market status and development trend of MRD Testing by types and applications
Cost and profit status of MRD Testing, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium MRD Testing market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the MRD Testing industry.

The report segments the global MRD Testing market as:

Global MRD Testing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa

Global MRD Testing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Other Technologies

Global MRD Testing Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Specialty Clinics and Hospitals
Diagnostic Laboratories
Research Institutions
Other End Users

Global MRD Testing Market: Manufacturers Segment Analysis (Company and Product introduction, MRD Testing Sales Volume, Revenue, Price and Gross Margin):
ICON
ArcherDX
Arup Laboratories
ASURAGEN INC
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
Laboratory Corporation of America Holdings
Inivata Ltd
Natera, Inc
NeoGenomics Laboratories, Inc
Opko Health
Quest Diagnostics Incorporated
Sysmex Corporation
Adaptive Biotechnologies Corporation

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MRD TESTING

1.1 Definition of MRD Testing in This Report
1.2 Commercial Types of MRD Testing
  1.2.1 Flow Cytometry
  1.2.2 Polymerase Chain Reaction (PCR)
  1.2.3 Next-Generation Sequencing (NGS)
  1.2.4 Other Technologies
1.3 Downstream Application of MRD Testing
  1.3.1 Specialty Clinics and Hospitals
  1.3.2 Diagnostic Laboratories
  1.3.3 Research Institutions
  1.3.4 Other End Users
1.4 Development History of MRD Testing
1.5 Market Status and Trend of MRD Testing 2016-2026
  1.5.1 Global MRD Testing Market Status and Trend 2016-2026
  1.5.2 Regional MRD Testing Market Status and Trend 2016-2026

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of MRD Testing 2016-2021
2.2 Sales Market of MRD Testing by Regions
  2.2.1 Sales Volume of MRD Testing by Regions
  2.2.2 Sales Value of MRD Testing by Regions
2.3 Production Market of MRD Testing by Regions
2.4 Global Market Forecast of MRD Testing 2022-2026
  2.4.1 Global Market Forecast of MRD Testing 2022-2026
  2.4.2 Market Forecast of MRD Testing by Regions 2022-2026

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Sales Volume of MRD Testing by Types
3.2 Sales Value of MRD Testing by Types
3.3 Market Forecast of MRD Testing by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Global Sales Volume of MRD Testing by Downstream Industry
4.2 Global Market Forecast of MRD Testing by Downstream Industry

CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

5.1 North America MRD Testing Market Status by Countries
  5.1.1 North America MRD Testing Sales by Countries (2016-2021)
  5.1.2 North America MRD Testing Revenue by Countries (2016-2021)
  5.1.3 United States MRD Testing Market Status (2016-2021)
  5.1.4 Canada MRD Testing Market Status (2016-2021)
  5.1.5 Mexico MRD Testing Market Status (2016-2021)
5.2 North America MRD Testing Market Status by Manufacturers
5.3 North America MRD Testing Market Status by Type (2016-2021)
  5.3.1 North America MRD Testing Sales by Type (2016-2021)
  5.3.2 North America MRD Testing Revenue by Type (2016-2021)
5.4 North America MRD Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

6.1 Europe MRD Testing Market Status by Countries
  6.1.1 Europe MRD Testing Sales by Countries (2016-2021)
  6.1.2 Europe MRD Testing Revenue by Countries (2016-2021)
  6.1.3 Germany MRD Testing Market Status (2016-2021)
  6.1.4 UK MRD Testing Market Status (2016-2021)
  6.1.5 France MRD Testing Market Status (2016-2021)
  6.1.6 Italy MRD Testing Market Status (2016-2021)
  6.1.7 Russia MRD Testing Market Status (2016-2021)
  6.1.8 Spain MRD Testing Market Status (2016-2021)
  6.1.9 Benelux MRD Testing Market Status (2016-2021)
6.2 Europe MRD Testing Market Status by Manufacturers
6.3 Europe MRD Testing Market Status by Type (2016-2021)
  6.3.1 Europe MRD Testing Sales by Type (2016-2021)
  6.3.2 Europe MRD Testing Revenue by Type (2016-2021)
6.4 Europe MRD Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

7.1 Asia Pacific MRD Testing Market Status by Countries
  7.1.1 Asia Pacific MRD Testing Sales by Countries (2016-2021)
  7.1.2 Asia Pacific MRD Testing Revenue by Countries (2016-2021)
  7.1.3 China MRD Testing Market Status (2016-2021)
  7.1.4 Japan MRD Testing Market Status (2016-2021)
  7.1.5 India MRD Testing Market Status (2016-2021)
  7.1.6 Southeast Asia MRD Testing Market Status (2016-2021)
  7.1.7 Australia MRD Testing Market Status (2016-2021)
7.2 Asia Pacific MRD Testing Market Status by Manufacturers
7.3 Asia Pacific MRD Testing Market Status by Type (2016-2021)
  7.3.1 Asia Pacific MRD Testing Sales by Type (2016-2021)
  7.3.2 Asia Pacific MRD Testing Revenue by Type (2016-2021)
7.4 Asia Pacific MRD Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

8.1 Latin America MRD Testing Market Status by Countries
  8.1.1 Latin America MRD Testing Sales by Countries (2016-2021)
  8.1.2 Latin America MRD Testing Revenue by Countries (2016-2021)
  8.1.3 Brazil MRD Testing Market Status (2016-2021)
  8.1.4 Argentina MRD Testing Market Status (2016-2021)
  8.1.5 Colombia MRD Testing Market Status (2016-2021)
8.2 Latin America MRD Testing Market Status by Manufacturers
8.3 Latin America MRD Testing Market Status by Type (2016-2021)
  8.3.1 Latin America MRD Testing Sales by Type (2016-2021)
  8.3.2 Latin America MRD Testing Revenue by Type (2016-2021)
8.4 Latin America MRD Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

9.1 Middle East and Africa MRD Testing Market Status by Countries
  9.1.1 Middle East and Africa MRD Testing Sales by Countries (2016-2021)
  9.1.2 Middle East and Africa MRD Testing Revenue by Countries (2016-2021)
  9.1.3 Middle East MRD Testing Market Status (2016-2021)
  9.1.4 Africa MRD Testing Market Status (2016-2021)
9.2 Middle East and Africa MRD Testing Market Status by Manufacturers
9.3 Middle East and Africa MRD Testing Market Status by Type (2016-2021)
  9.3.1 Middle East and Africa MRD Testing Sales by Type (2016-2021)
  9.3.2 Middle East and Africa MRD Testing Revenue by Type (2016-2021)
9.4 Middle East and Africa MRD Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF MRD TESTING

10.1 Global Economy Situation and Trend Overview
10.2 MRD Testing Downstream Industry Situation and Trend Overview

CHAPTER 11 MRD TESTING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

11.1 Production Volume of MRD Testing by Major Manufacturers
11.2 Production Value of MRD Testing by Major Manufacturers
11.3 Basic Information of MRD Testing by Major Manufacturers
  11.3.1 Headquarters Location and Established Time of MRD Testing Major Manufacturer
  11.3.2 Employees and Revenue Level of MRD Testing Major Manufacturer
11.4 Market Competition News and Trend
  11.4.1 Merger, Consolidation or Acquisition News
  11.4.2 Investment or Disinvestment News
  11.4.3 New Product Development and Launch

CHAPTER 12 MRD TESTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

12.1 ICON
  12.1.1 Company profile
  12.1.2 Representative MRD Testing Product
  12.1.3 MRD Testing Sales, Revenue, Price and Gross Margin of ICON
12.2 ArcherDX
  12.2.1 Company profile
  12.2.2 Representative MRD Testing Product
  12.2.3 MRD Testing Sales, Revenue, Price and Gross Margin of ArcherDX
12.3 Arup Laboratories
  12.3.1 Company profile
  12.3.2 Representative MRD Testing Product
  12.3.3 MRD Testing Sales, Revenue, Price and Gross Margin of Arup Laboratories
12.4 ASURAGEN INC
  12.4.1 Company profile
  12.4.2 Representative MRD Testing Product
  12.4.3 MRD Testing Sales, Revenue, Price and Gross Margin of ASURAGEN INC
12.5 Cergentis B.V.
  12.5.1 Company profile
  12.5.2 Representative MRD Testing Product
  12.5.3 MRD Testing Sales, Revenue, Price and Gross Margin of Cergentis B.V.
12.6 Bio-Rad Laboratories
  12.6.1 Company profile
  12.6.2 Representative MRD Testing Product
  12.6.3 MRD Testing Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories
12.7 Mission Bio
  12.7.1 Company profile
  12.7.2 Representative MRD Testing Product
  12.7.3 MRD Testing Sales, Revenue, Price and Gross Margin of Mission Bio
12.8 Guardant Health
  12.8.1 Company profile
  12.8.2 Representative MRD Testing Product
  12.8.3 MRD Testing Sales, Revenue, Price and Gross Margin of Guardant Health
12.9 Invivoscribe
  12.9.1 Company profile
  12.9.2 Representative MRD Testing Product
  12.9.3 MRD Testing Sales, Revenue, Price and Gross Margin of Invivoscribe
12.10 Laboratory Corporation of America Holdings
  12.10.1 Company profile
  12.10.2 Representative MRD Testing Product
  12.10.3 MRD Testing Sales, Revenue, Price and Gross Margin of Laboratory Corporation of America Holdings
12.11 Inivata Ltd
  12.11.1 Company profile
  12.11.2 Representative MRD Testing Product
  12.11.3 MRD Testing Sales, Revenue, Price and Gross Margin of Inivata Ltd
12.12 Natera, Inc
  12.12.1 Company profile
  12.12.2 Representative MRD Testing Product
  12.12.3 MRD Testing Sales, Revenue, Price and Gross Margin of Natera, Inc
12.13 NeoGenomics Laboratories, Inc
  12.13.1 Company profile
  12.13.2 Representative MRD Testing Product
  12.13.3 MRD Testing Sales, Revenue, Price and Gross Margin of NeoGenomics Laboratories, Inc
12.14 Opko Health
  12.14.1 Company profile
  12.14.2 Representative MRD Testing Product
  12.14.3 MRD Testing Sales, Revenue, Price and Gross Margin of Opko Health
12.15 Quest Diagnostics Incorporated
  12.15.1 Company profile
  12.15.2 Representative MRD Testing Product
  12.15.3 MRD Testing Sales, Revenue, Price and Gross Margin of Quest Diagnostics Incorporated
12.16 Sysmex Corporation
12.17 Adaptive Biotechnologies Corporation

CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MRD TESTING

13.1 Industry Chain of MRD Testing
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF MRD TESTING

14.1 Cost Structure Analysis of MRD Testing
14.2 Raw Materials Cost Analysis of MRD Testing
14.3 Labor Cost Analysis of MRD Testing
14.4 Manufacturing Expenses Analysis of MRD Testing

CHAPTER 15 REPORT CONCLUSION

CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Reference


More Publications